FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions - FDA Press Releases

The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.

from Food and Drug Administration--Press Releases http://ift.tt/2ho62rP
via IFTTT